Literature DB >> 25431616

The RNA-dependent RNA polymerase of the influenza A virus.

Thomas M Stubbs1, Aartjan Jw Te Velthuis2.   

Abstract

The influenza A virus causes a highly contagious respiratory disease that significantly impacts our economy and health. Its replication and transcription is catalyzed by the viral RNA polymerase. This enzyme is also crucial for the virus, because it is involved in the adaptation of zoonotic strains. It is thus of major interest for the development of antiviral therapies and is being intensively studied. In this article, we will discuss recent advances that have improved our knowledge of the structure of the RNA polymerase and how mutations in the polymerase help the virus to spread effectively among new hosts.

Entities:  

Keywords:  RNA polymerase; adaptation; host restriction; influenza A; replication; structure; transcription

Year:  2014        PMID: 25431616      PMCID: PMC4243023          DOI: 10.2217/fvl.14.66

Source DB:  PubMed          Journal:  Future Virol        ISSN: 1746-0794            Impact factor:   1.831


  97 in total

1.  An inhibitory activity in human cells restricts the function of an avian-like influenza virus polymerase.

Authors:  Andrew Mehle; Jennifer A Doudna
Journal:  Cell Host Microbe       Date:  2008-08-14       Impact factor: 21.023

2.  Biochemical impact of the host adaptation-associated PB2 E627K mutation on the temperature-dependent RNA synthesis kinetics of influenza A virus polymerase complex.

Authors:  Shilpa Aggarwal; Stephen Dewhurst; Toru Takimoto; Baek Kim
Journal:  J Biol Chem       Date:  2011-08-04       Impact factor: 5.157

3.  Nuclear import and assembly of influenza A virus RNA polymerase studied in live cells by fluorescence cross-correlation spectroscopy.

Authors:  Sébastien Huet; Sergiy V Avilov; Lars Ferbitz; Nathalie Daigle; Stephen Cusack; Jan Ellenberg
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

4.  Identification of novel influenza A virus proteins translated from PA mRNA.

Authors:  Yukiko Muramoto; Takeshi Noda; Eiryo Kawakami; Ramesh Akkina; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2012-12-12       Impact factor: 5.103

5.  Behaviour of influenza A viruses differentially expressing segment 2 gene products in vitro and in vivo.

Authors:  Sandra Tauber; Yvonne Ligertwood; Marlynne Quigg-Nicol; Bernadette M Dutia; Richard M Elliott
Journal:  J Gen Virol       Date:  2011-12-21       Impact factor: 3.891

6.  Structural insight into the essential PB1-PB2 subunit contact of the influenza virus RNA polymerase.

Authors:  Kanako Sugiyama; Eiji Obayashi; Atsushi Kawaguchi; Yukari Suzuki; Jeremy R H Tame; Kyosuke Nagata; Sam-Yong Park
Journal:  EMBO J       Date:  2009-05-21       Impact factor: 11.598

7.  The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit.

Authors:  Alexandre Dias; Denis Bouvier; Thibaut Crépin; Andrew A McCarthy; Darren J Hart; Florence Baudin; Stephen Cusack; Rob W H Ruigrok
Journal:  Nature       Date:  2009-02-04       Impact factor: 49.962

8.  Interaction of polymerase subunit PB2 and NP with importin alpha1 is a determinant of host range of influenza A virus.

Authors:  Gülsah Gabriel; Astrid Herwig; Hans-Dieter Klenk
Journal:  PLoS Pathog       Date:  2008-02-08       Impact factor: 6.823

9.  Host determinant residue lysine 627 lies on the surface of a discrete, folded domain of influenza virus polymerase PB2 subunit.

Authors:  Franck Tarendeau; Thibaut Crepin; Delphine Guilligay; Rob W H Ruigrok; Stephen Cusack; Darren J Hart
Journal:  PLoS Pathog       Date:  2008-08-29       Impact factor: 6.823

10.  Avian Influenza virus glycoproteins restrict virus replication and spread through human airway epithelium at temperatures of the proximal airways.

Authors:  Margaret A Scull; Laura Gillim-Ross; Celia Santos; Kim L Roberts; Elena Bordonali; Kanta Subbarao; Wendy S Barclay; Raymond J Pickles
Journal:  PLoS Pathog       Date:  2009-05-15       Impact factor: 6.823

View more
  17 in total

1.  Structures and functions linked to genome-wide adaptation of human influenza A viruses.

Authors:  Thorsten R Klingen; Jens Loers; Stephanie Stanelle-Bertram; Gülsah Gabriel; Alice C McHardy
Journal:  Sci Rep       Date:  2019-04-18       Impact factor: 4.379

2.  p21 restricts influenza A virus by perturbing the viral polymerase complex and upregulating type I interferon signaling.

Authors:  Chao Ma; Yuhan Li; Yanan Zong; Tony Velkov; Chenxi Wang; Xinyu Yang; Ming Zhang; Zhimin Jiang; Haoran Sun; Qi Tong; Honglei Sun; Juan Pu; Munir Iqbal; Jinhua Liu; Chongshan Dai; Yipeng Sun
Journal:  PLoS Pathog       Date:  2022-02-18       Impact factor: 6.823

Review 3.  1,2,4-Triazolo[1,5-a]pyrimidines in drug design.

Authors:  Killian Oukoloff; Bobby Lucero; Karol R Francisco; Kurt R Brunden; Carlo Ballatore
Journal:  Eur J Med Chem       Date:  2019-01-14       Impact factor: 6.514

Review 4.  RNA Dependent RNA Polymerases: Insights from Structure, Function and Evolution.

Authors:  Sangita Venkataraman; Burra V L S Prasad; Ramasamy Selvarajan
Journal:  Viruses       Date:  2018-02-10       Impact factor: 5.048

5.  Host Long Noncoding RNA lncRNA-PAAN Regulates the Replication of Influenza A Virus.

Authors:  Jing Wang; Yujia Wang; Rui Zhou; Jianyuan Zhao; Yongxin Zhang; Dongrong Yi; Quanjie Li; Jinming Zhou; Fei Guo; Chen Liang; Xiaoyu Li; Shan Cen
Journal:  Viruses       Date:  2018-06-16       Impact factor: 5.048

6.  Grail attenuates influenza A virus infection and pathogenesis by inhibiting viral nucleoprotein.

Authors:  Hui-Tsu Lin; Cheng-Cheung Chen; Pei-Yao Liu; Hsueh-Ling Wu; Ti-Hui Wu; Chih-Heng Huang; Ying-Chuan Chen
Journal:  Sci Rep       Date:  2018-11-22       Impact factor: 4.379

7.  Synthesis and Antiviral Evaluation of Nucleoside Analogues Bearing One Pyrimidine Moiety and Two D-Ribofuranosyl Residues.

Authors:  Olga V Andreeva; Bulat F Garifullin; Vladimir V Zarubaev; Alexander V Slita; Iana L Yesaulkova; Alexandrina S Volobueva; Mayya G Belenok; Maria A Man'kova; Liliya F Saifina; Marina M Shulaeva; Alexandra D Voloshina; Anna P Lyubina; Vyacheslav E Semenov; Vladimir E Kataev
Journal:  Molecules       Date:  2021-06-16       Impact factor: 4.411

Review 8.  Perspective of Use of Antiviral Peptides against Influenza Virus.

Authors:  Sylvie Skalickova; Zbynek Heger; Ludmila Krejcova; Vladimir Pekarik; Karel Bastl; Jozef Janda; Frantisek Kostolansky; Eva Vareckova; Ondrej Zitka; Vojtech Adam; Rene Kizek
Journal:  Viruses       Date:  2015-10-20       Impact factor: 5.048

9.  Computational target-based drug repurposing of elbasvir, an antiviral drug predicted to bind multiple SARS-CoV-2 proteins.

Authors:  Meenakshisundaram Balasubramaniam; Robert J Shmookler Reis
Journal:  ChemRxiv       Date:  2020-04-08

10.  Synthesis of 1,2,3-triazolyl nucleoside analogues and their antiviral activity.

Authors:  Olga V Andreeva; Bulat F Garifullin; Vladimir V Zarubaev; Alexander V Slita; Iana L Yesaulkova; Liliya F Saifina; Marina M Shulaeva; Maya G Belenok; Vyacheslav E Semenov; Vladimir E Kataev
Journal:  Mol Divers       Date:  2020-09-15       Impact factor: 2.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.